Ranexa® has been studied in multiple clinical trials, which provide important information on its most common adverse events reported in angina patients and its use in special populations.
In controlled clinical trials of angina patients, the most frequently reported treatment-emergent adverse reactions (>4% and more common on Ranexa than on placebo) were dizziness, headache, constipation, and nausea.1
*Dizziness may be dose related.
Review the CARISA and TERISA clinical trials to learn how Ranexa may help reduce the symptoms of chronic angina.View Clinical Data
Learn about safety data from the Ranexa clinical trials, including use in special populations.Review Safety & Tolerability
Ranexa Connect™ is a financial assistance resource for patients with a Ranexa prescription.
Ranexa Connect is pleased to announce iAssist, a program to help get your patients started on Ranexa faster. The program offers online patient enrollment, electronic signatures, as well as real-time pharmacy benefit check and eligibility for financial assistance.Get Started Now
1. Ranexa [package insert]. Foster City, CA: Gilead Sciences, Inc.; January 2016.